On 2025-05-14, AEON Biopharma, Inc. (AEON) announced earnings per share of $-0.09 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-13.67.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-13.67 | $-0.09 |
| 2025-03-24 | 2024-12-31 | $-12.95 | $3.75 |
| 2024-11-13 | 2024-09-30 | $-11.51 | $-11.51 |
| 2024-08-12 | 2024-06-30 | $-13.67 | $-11.51 |
| 2024-05-14 | 2024-03-31 | $-22.30 | $-20.14 |
| 2024-03-29 | 2023-12-31 | -- | $-51.08 |